Family Aggregation and Heritability of ESRD in Taiwan: A Population-Based Study Hsin Hsu Wu, MD, Chang Fu Kuo, MD, PhD, I. Jung Li, MD, Cheng Hao Weng, MD, Cheng Chia Lee, MD, Kun Hua Tu, MD, Shou Hsuan Liu, MD, Yung Chang Chen, MD, Chih Wei Yang, MD, Shue Fen Luo, MD, Lai Chu See, PhD, Kuang Hui Yu, MD, Lu Hsiang Huang, MSc, Weiya Zhang, MD, PhD, Michael Doherty, MD, Ya Chung Tian, MD, PhD American Journal of Kidney Diseases Volume 70, Issue 5, Pages 619-626 (November 2017) DOI: 10.1053/j.ajkd.2017.05.007 Copyright © 2017 The Authors Terms and Conditions
Figure 1 Comparisons of (A) age-specific prevalence and (B) onset age–specific prevalence of end-stage renal disease (ESRD) between individuals with a first-degree relative with ESRD and the general population in Taiwan in 2013. Error bars indicate 95% confidence interval. American Journal of Kidney Diseases 2017 70, 619-626DOI: (10.1053/j.ajkd.2017.05.007) Copyright © 2017 The Authors Terms and Conditions
Figure 2 Relative risks for end-stage renal disease (ESRD) in individuals with affected relatives. Error bars indicate 95% confidence interval (CI). American Journal of Kidney Diseases 2017 70, 619-626DOI: (10.1053/j.ajkd.2017.05.007) Copyright © 2017 The Authors Terms and Conditions